OneMedNet (NASDAQ:ONMD) Director Thomas Kosasa Acquires 158,730 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 158,730 shares of OneMedNet stock in a transaction on Friday, June 12th. The shares were acquired at an average price of $0.63 per share, with a total value of $99,999.90. Following the transaction, the director directly owned 17,088,874 shares in the company, valued at $10,765,990.62. This trade represents a 0.94% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Thomas Kosasa also recently made the following trade(s):

• On Monday, May 18th, Thomas Kosasa purchased 268,817 shares of OneMedNet stock. The stock was acquired at an average cost of $0.93 per share, with a total value of $249,999.81.
• On Thursday, April 23rd, Thomas Kosasa purchased 280,898 shares of OneMedNet stock. The shares were acquired at an average cost of $0.89 per share, for a total transaction of $249,999.22.

OneMedNet Stock Up 2.7%

Shares of NASDAQ ONMD opened at $0.56 on Tuesday. The stock has a market cap of $30.37 million, a P/E ratio of -11.16 and a beta of 1.12. The firm’s 50-day simple moving average is $0.87 and its 200 day simple moving average is $0.96. OneMedNet Corporation has a fifty-two week low of $0.31 and a fifty-two week high of $4.22.

OneMedNet (NASDAQ:ONMD) last announced its earnings results on Friday, May 15th. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $0.10 million for the quarter.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Wall Street Zen downgraded OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, OneMedNet presently has a consensus rating of “Sell”.

Institutional Trading of OneMedNet

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Virtu Financial LLC acquired a new stake in OneMedNet during the fourth quarter valued at approximately $48,000. State Street Corp grew its position in OneMedNet by 41.5% in the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after buying an additional 34,200 shares during the last quarter. Jane Street Group LLC bought a new position in shares of OneMedNet in the fourth quarter valued at $119,000. HRT Financial LP bought a new position in shares of OneMedNet in the fourth quarter valued at $32,000. Finally, Exencial Wealth Advisors LLC lifted its position in shares of OneMedNet by 1.3% during the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after acquiring an additional 45,401 shares during the last quarter. 0.95% of the stock is currently owned by institutional investors.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.